Akebia Therapeutics, Inc. financial data

Symbol
AKBA on Nasdaq
Industry
Pharmaceutical Preparations
Location
245 First Street, Cambridge, MA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Mar 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 137 % +5.45%
Quick Ratio 26.9 % +28.1%
Debt-to-equity -644 % +33.8%
Return On Equity 173 % -3.51%
Return On Assets -31.8 % -54.8%
Operating Margin -31.5 % -32.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 236M shares +12.8%
Common Stock, Shares, Outstanding 225M shares +15.6%
Entity Public Float 211M USD +24.3%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 211M shares +12.5%
Weighted Average Number of Shares Outstanding, Diluted 211M shares +12.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 160M USD -17.7%
Cost of Revenue 63.2M USD -14.8%
Research and Development Expense 37.7M USD -40.3%
Operating Income (Loss) -50.5M USD -9.11%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -69.4M USD -33.7%
Net Income (Loss) Attributable to Parent -69.4M USD -33.7%
Earnings Per Share, Basic -0.33 USD/shares -17.9%
Earnings Per Share, Diluted -0.33 USD/shares -17.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 51.9M USD +20.8%
Accounts Receivable, after Allowance for Credit Loss, Current 34.4M USD -12.5%
Inventory, Net 16.2M USD +3.52%
Other Assets, Current 7.32M USD +27.2%
Assets, Current 114M USD -3.66%
Property, Plant and Equipment, Net 2.2M USD -39.4%
Operating Lease, Right-of-Use Asset 8.22M USD -33.8%
Intangible Assets, Net (Excluding Goodwill) 0 USD -100%
Goodwill 59M USD 0%
Other Assets, Noncurrent 37.4M USD +201%
Assets 221M USD -8.7%
Accounts Payable, Current 15.2M USD +3.72%
Employee-related Liabilities, Current 9.19M USD +11.9%
Accrued Liabilities, Current 63.5M USD -6.31%
Contract with Customer, Liability, Current 43.3M USD
Liabilities, Current 80.9M USD -19%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 3.55M USD -60.4%
Other Liabilities, Noncurrent 4.75M USD -46.6%
Liabilities 270M USD -0.89%
Accumulated Other Comprehensive Income (Loss), Net of Tax 6K USD 0%
Retained Earnings (Accumulated Deficit) -1.68B USD -4.31%
Stockholders' Equity Attributable to Parent -49.2M USD -60.8%
Liabilities and Equity 221M USD -8.7%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -19.4M USD -10.8%
Net Cash Provided by (Used in) Financing Activities 18.5M USD
Net Cash Provided by (Used in) Investing Activities 0 USD
Common Stock, Shares Authorized 350M shares 0%
Common Stock, Shares, Issued 225M shares +15.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -957K USD +97.1%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 53.6M USD +20.1%
Deferred Tax Assets, Valuation Allowance 388M USD +6.15%
Deferred Tax Assets, Gross 391M USD +3.77%
Operating Lease, Liability 8.95M USD -33.4%
Depreciation 364K USD -8.54%
Payments to Acquire Property, Plant, and Equipment 0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -69.4M USD -33.7%
Lessee, Operating Lease, Liability, to be Paid 9.43M USD -35.8%
Operating Lease, Liability, Current 5.4M USD +20.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.61M USD -37.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.82M USD +10.6%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 485K USD -61.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 3.61M USD -56.4%
Deferred Tax Assets, Operating Loss Carryforwards 292M USD +0.96%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.57M USD -60.9%
Operating Lease, Payments 5.7M USD -3.39%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 36M USD 0%
Deferred Tax Assets, Net of Valuation Allowance 3.38M USD -71%
Share-based Payment Arrangement, Expense 7.78M USD -16.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%